A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Amid National Opioid Crisis, Rubio & Klobuchar Introduce Bill to Eliminate Patient Brokering
Washington, D.C. – U.S. Senators Marco Rubio (R-FL) and Amy Klobuchar (D-MN) yesterday introduced the Eliminating Kickbacks in Recovery Act, legislation to prohibit patient brokering by punishing unscrupulous actors that prey on patients seeking treatment in order to exploit the patient’s insurance. In May, Rubio introduced legislation to help states, law enforcement, private insurers and patients identify potentially illicit treatment centers and sober homes to ensure those who need treatment are able to find legitimate facilities.
“Too many Americans suffering as a result of the opioid epidemic are exploited by bad actors seeking to make a profit from addiction,” Rubio said. “This bill will help stop the cash flow for middlemen involved in illicit sober homes and paid referrals. I remain committed to addressing this important issue that has left no part of the state untouched.”
“When people are struggling with addiction, their focus should be on getting well, not on worrying whether treatment facilities are trying to take advantage of them to make more money,” said Klobuchar. “Our bipartisan bill will crack down on health care facilities or providers that try to game the system to take advantage of vulnerable patients.”
“It is critical that our federal partners have the tools available to assist local efforts to stem the fraud and abuse that has decimated the legitimate treatment industry. We appreciate the support from Senators Rubio and Klobuchar to empower federal prosecutors to go after corrupt kickbacks to patient brokers,” said Palm Beach State Attorney Dave Aronberg, who leads the Sober Homes Task Force in South Florida and brought the issue of patient brokering to Senator Rubio’s attention.
The Eliminating Kickbacks in Recovery Act would:
- Make it illegal to provide, or receive, financial kickbacks for referring patients to recovery homes and clinical treatment facilities. These kickbacks are already illegal under Federal health care plans, like Medicare, but there is no federal law to prohibit them in private health insurance plans;
- Fine anyone found guilty up to $200,000 or 10 years of prison, or both;
- Establish common-sense exceptions to enable legitimate cases of patient referral.